NeuroMetrix Inc.
62 Fourth Ave
Waltham
MA
02451
United States
(781) 890-9989
Product(s):
Develops non-invasive testing for neuromuscular disorders
Ownership:
Public
Exchange:
NSDQ
symbol:
NURO
2004 Revenue:
$17,920,089
2005 Revenue:
$34,298,133
2006 Revenue:
$55,249,716
2007 Revenue:
$44,622,211
2008 Revenue:
$31,120,800
Yahoo Quotes:
Chairman:
Shai N. Gozani
President:
Shai N. Gozani
CEO:
Shai N. Gozani Management:
Guy Daniello, SVP-IT
Michael Williams, SVP-engineering
Joe Calo, CFO
Xuan Kong, VP-research
Charles Fendrock, VP-manufacturing, intellectual property and strategic innovation
Michael J. MacDonald, VP-marketing
NeuroMetrix Inc.
Permalink
RECENT BLOG POSTS
- Mobilizing on the back end of a disaster
- Rising healthcare costs not directly tied to medical technology, according to study
- CareFusion may be weighing 2 very different deals
- Medical Devices: What does it really mean to be disruptive?
- Smarter strategic moves bode well for Wright Medical
- The IRS, NSA, and Justice Department scandals and what they mean for HIPAA
- A Father's Day remembrance
- What I'd tell the graduating medical school class of 2013
- Silencing immune attacks in type 1 diabetes
- Eucomed guidance clarifies RoHS compliance for medical device companies
